Concepts (55)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oncolytic Virotherapy | 9 | 2024 | 106 | 2.780 |
Why?
|
| Oncolytic Viruses | 7 | 2024 | 84 | 2.000 |
Why?
|
| Adenoviridae | 7 | 2024 | 579 | 1.830 |
Why?
|
| Neoplasms | 8 | 2025 | 3016 | 0.970 |
Why?
|
| Immunotherapy, Adoptive | 4 | 2021 | 960 | 0.900 |
Why?
|
| Cell Plasticity | 1 | 2025 | 42 | 0.850 |
Why?
|
| Myeloid Cells | 1 | 2025 | 113 | 0.850 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2025 | 111 | 0.850 |
Why?
|
| Alternative Splicing | 1 | 2025 | 307 | 0.780 |
Why?
|
| T-Lymphocytes | 4 | 2024 | 1722 | 0.570 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 196 | 0.560 |
Why?
|
| Inflammation | 1 | 2025 | 1489 | 0.530 |
Why?
|
| Adoptive Transfer | 1 | 2018 | 235 | 0.520 |
Why?
|
| Genetic Therapy | 2 | 2020 | 713 | 0.450 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 1216 | 0.440 |
Why?
|
| Interleukin-12 | 3 | 2021 | 125 | 0.430 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 740 | 0.430 |
Why?
|
| B7-H1 Antigen | 3 | 2021 | 136 | 0.390 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 750 | 0.350 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 638 | 0.350 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2024 | 1011 | 0.340 |
Why?
|
| Tumor Burden | 2 | 2021 | 240 | 0.280 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2020 | 502 | 0.230 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2017 | 688 | 0.220 |
Why?
|
| Immunity, Innate | 1 | 2025 | 406 | 0.180 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 3748 | 0.170 |
Why?
|
| Single-Chain Antibodies | 1 | 2021 | 42 | 0.160 |
Why?
|
| Coculture Techniques | 1 | 2021 | 230 | 0.160 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 713 | 0.150 |
Why?
|
| Animals | 7 | 2025 | 33912 | 0.150 |
Why?
|
| Antibodies, Bispecific | 1 | 2020 | 51 | 0.150 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 713 | 0.140 |
Why?
|
| Antibodies, Neoplasm | 1 | 2017 | 55 | 0.130 |
Why?
|
| Lymphocyte Transfusion | 1 | 2017 | 55 | 0.130 |
Why?
|
| Viral Tropism | 1 | 2016 | 55 | 0.110 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 276 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2017 | 1483 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2017 | 525 | 0.100 |
Why?
|
| Gene Expression | 1 | 2017 | 1481 | 0.100 |
Why?
|
| Humans | 8 | 2025 | 131163 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 981 | 0.080 |
Why?
|
| Mice | 4 | 2024 | 18301 | 0.080 |
Why?
|
| Female | 5 | 2024 | 70963 | 0.060 |
Why?
|
| Clinical Studies as Topic | 1 | 2020 | 11 | 0.040 |
Why?
|
| Hyaluronan Receptors | 1 | 2020 | 64 | 0.040 |
Why?
|
| Male | 3 | 2021 | 64957 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 299 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2024 | 768 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2020 | 585 | 0.040 |
Why?
|
| A549 Cells | 1 | 2017 | 47 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2020 | 892 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 83 | 0.030 |
Why?
|
| Cytokines | 1 | 2023 | 1339 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2017 | 700 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 12936 | 0.030 |
Why?
|